In this podcast, Dana E. King, MD, discusses his team’s latest research that examined the association between glucosamine/chondroitin supplement use and mortality rates, as well as what the study results...
In this podcast, Dana E. King, MD, discusses his team’s latest research that examined the association between glucosamine/chondroitin supplement use and mortality rates, as well as what the study results...
In this podcast, Dana E. King, MD, discusses his team’s latest research that examined the association between glucosamine/chondroitin supplement use and mortality rates, as well as what the study results...
In this podcast, Timothy Bhattacharyya, MD, discusses declining trends in hip fractures seen over the last 40 years, how osteoporosis treatment efforts relate to these trends, and what factors have had the...
In this podcast, Timothy Bhattacharyya, MD, discusses declining trends in hip fractures seen over the last 40 years, how osteoporosis treatment efforts relate to these trends, and what factors have had the...
In this podcast, Timothy Bhattacharyya, MD, discusses declining trends in hip fractures seen over the last 40 years, how osteoporosis treatment efforts relate to these trends, and what factors have had the...
Elizabeth Volkmann, MD, discusses her research into the association of the gut microbiome with systemic sclerosis, environmental influences on the microbiota, and advances in treating the disease.
Elizabeth Volkmann, MD, discusses her research into the association of the gut microbiome with systemic sclerosis, environmental influences on the microbiota, and advances in treating the disease.
Elizabeth Volkmann, MD, discusses her research into the association of the gut microbiome with systemic sclerosis, environmental influences on the microbiota, and advances in treating the disease.
In this podcast, Harrys A. Torres, MD, talks about his team's study that aimed to identify the optimal screening test for hepatitis C virus in patients with hematologic malignancies and/or prior...
